Literature DB >> 26609209

Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

George DeMaagd, Ashok Philip.   

Abstract

Parkinson's motor complications include wearing-off, a delayed or absent response to carbidopa/levodopa therapy, freezing of gait, dyskinesias, and dystonias. Treatment may include medication adjustments, such as increased dopaminergic stimulation.

Entities:  

Year:  2015        PMID： 26609209      PMCID： PMC4634347     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  108 in total

1.  N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis.

Authors:  Behzad Elahi; Nicolás Phielipp; Robert Chen
Journal:  Can J Neurol Sci       Date:  2012-07       Impact factor: 2.104

2.  Botulinum toxin injections do not improve freezing of gait in Parkinson disease.

Authors:  Marguerite Wieler; Richard Camicioli; C Allyson Jones; W R Wayne Martin
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

3.  Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.

Authors:  A Colzi; K Turner; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

4.  Patient perception of dyskinesia in Parkinson's disease.

Authors:  S W Hung; G M Adeli; T Arenovich; S H Fox; A E Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-28       Impact factor: 10.154

Review 5.  Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.

Authors:  Rebecca Stowe; Natalie Ives; Carl E Clarke; Kelly Handley; Alexandra Furmston; Katherine Deane; J J van Hilten; Keith Wheatley; Richard Gray
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

6.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Authors:  Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

7.  Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study.

Authors:  Barb Lennert; Wendy Bibeau; Eileen Farrelly; Patricia Sacco; Tessa Schoor
Journal:  Am Health Drug Benefits       Date:  2012-09

8.  Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.

Authors: 
Journal:  Arch Neurol       Date:  2009-05

Review 9.  Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.

Authors:  Carlo Colosimo; Pablo Martínez-Martín; Giovanni Fabbrini; Robert A Hauser; Marcelo Merello; Janis Miyasaki; Werner Poewe; Cristina Sampaio; Olivier Rascol; Glenn T Stebbins; Anette Schrag; Christopher G Goetz
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 10.  Serotonin and Parkinson's disease: On movement, mood, and madness.

Authors:  Susan H Fox; Rosalind Chuang; Jonathan M Brotchie
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338
View more
  9 in total

Review 1.  Motor Complications of Dopaminergic Medications in Parkinson's Disease.

Authors:  Maria Eliza Freitas; Christopher W Hess; Susan H Fox
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

2.  Nonmotor symptoms in patients with Parkinson disease: A cross-sectional observational study.

Authors:  Tie-Mei Zhang; Shu-Yang Yu; Peng Guo; Yang Du; Yang Hu; Ying-Shan Piao; Li-Jun Zuo; Teng-Hong Lian; Rui-Dan Wang; Qiu-Jin Yu; Zhao Jin; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

3.  Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson's disease.

Authors:  Nobutaka Hattori; Atsushi Takeda; Shinichi Takeda; Akira Nishimura; Ryou Nakaya; Hideki Mochizuki; Masahiro Nagai; Ryosuke Takahashi
Journal:  J Neural Transm (Vienna)       Date:  2019-01-11       Impact factor: 3.575

Review 4.  Estimands: bringing clarity and focus to research questions in clinical trials.

Authors:  Timothy Peter Clark; Brennan C Kahan; Alan Phillips; Ian White; James R Carpenter
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

5.  Professionals' Self-Reported Difficulties towards Integrating Dual Task Training in Care for People with Parkinson's Disease.

Authors:  Josefa Domingos; John Dean; Júlio Belo Fernandes; Catarina Godinho
Journal:  Int J Environ Res Public Health       Date:  2022-01-24       Impact factor: 3.390

6.  Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease.

Authors:  Andrew Thach; Noam Kirson; Miriam L Zichlin; Ibrahima Dieye; Eric Pappert; G Rhys Williams
Journal:  J Health Econ Outcomes Res       Date:  2021-11-17

7.  The distorted body: The perception of the relative proportions of the body is preserved in Parkinson's disease.

Authors:  Megan Rose Readman; Matthew R Longo; Neil M McLatchie; Trevor J Crawford; Sally A Linkenauger
Journal:  Psychon Bull Rev       Date:  2022-04-20

8.  Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.

Authors:  Emmanuel Vazquez-Mayorga; Mariana Grigoruta; Raul Dagda; Bridget Martinez; Ruben K Dagda
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

9.  Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review.

Authors:  Jikke T Boelens Keun; Ilse Ac Arnoldussen; Chris Vriend; Ondine van de Rest
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.